Skip to content

PHARMAFORM

Absorbed by 3P DALHEM on 07-01-2015 KBO/BCE: BE 0475.742.240

Timeline

21 events since 2001
2015
Merger: absorbed by 3P DALHEMDissolution of the company · Dissolved without liquidation · 3P DALHEM holds all the shares · General meeting of 16-12-20143 points ▸
  • General meeting of 16-12-2014
  • 3P DALHEM holds all the shares
  • The operation takes effect in the accounts on 01-01-2014
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

2014
Annual accounts 2013 filed PDFfull format · 25 days late
Merger proposal: to be absorbed by 3P DALHEM3P DALHEM holds all the shares5 points ▸
  • Merger by absorption
  • The capital is divided into 250 shares
  • The capital is divided into 100 shares
  • 3P DALHEM holds all the shares
  • The operation takes effect in the accounts on 01-01-2014
  • The deed holds 8 more points.

Open the deed in the Belgian Official Gazette

Registered office moved within HerstalThe registered office moved from Rue de l'Abbaye 95 à 4040 Herstal to 1ère Avenue 22/40 à 4040 HERSTAL · General meeting of 30-12-20132 points ▸
  • General meeting of 30-12-2013
  • The registered office moved to 1ère Avenue 22/40 à 4040 HERSTAL

Open the deed in the Belgian Official Gazette

2013
Annual accounts 2012 filed PDFfull format · 28 days late
2012
Highest result from 2006 to 2013 net €54,645 ▲39% The net result of €54,645 is the highest of those years.
Annual accounts 2011 filed PDFfull format · 28 days late
Registered office moved from Genk to HerstalThe registered office moved from Toekomstlaan 34, 3600 Genk to Rue de l'Abbaye 95, 4040 Herstal · resigns as manager · appointed as manager5 points ▸
  • The registered office moved to Rue de l'Abbaye 95, 4040 Herstal
  • resigns as manager
  • Discharge granted to (manager)
  • appointed as manager
  • The capital is €70,000, divided into 100 shares
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

2011
Back to profit net €39,312 The net result is €39,312, after 2 loss-making years.
Annual accounts 2010 filed PDFfull format · 110 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 31 days late
2009
Annual accounts 2008 filed PDFabbreviated format · 35 days before the deadline
2008
Liquidity more than 7 times current ratio 2.87 The current ratio rises from 0.40 to 2.87. Short-term debt falls from €55,941 to €27,345.
Annual accounts 2007 filed PDFabbreviated format · 41 days before the deadline
2007
Back to profit net €7,893 The net result is €7,893, after one loss-making year.
Annual accounts 2006 filed PDFabbreviated format · 20 days before the deadline
2006
Annual accounts 2005 filed PDFfull format · 31 days late
2005
Annual accounts 2004 filed PDFfull format · 37 days late
2004
Annual accounts 2003 filed PDFfull format
2003
Annual accounts 2002 filed PDFfull format
2001
Incorporation 15 publications in the Belgian Official Gazette, the last on 07-01-2015

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

The registered office was moved to Herstal in 2012.1 PHARMAFORM has filed 12 sets of annual accounts, the latest for financial year 2013.2 In 2015 the company was absorbed by merger into 3P DALHEM.3

  1. 1Belgian Official Gazette, 18-01-2012
  2. 2National Bank, annual accounts 2013
  3. 3Belgian Official Gazette, 07-01-2015